CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) € in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2021 EUR (€) shares	Jun. 30, 2020 USD ($) $ / shares shares	Jun. 30, 2020 EUR (€) shares	Jun. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2021 EUR (€) shares	Jun. 30, 2020 USD ($) $ / shares shares	Jun. 30, 2020 EUR (€) shares
Revenue
Research and development | $	$ 0		$ 11,000		$ 3,000		$ 28,000
Grants | €		€ 159		€ 134		€ 290		€ 389
Revenue net | €		159		145		293		417
Expenses
Research and development expenses | $	308,000		252,000		562,000		574,000
General and administrative | $	277,000		296,000		568,000		621,000
Expenses net | €		585		548		1,130		1,195
Operating Loss | €		(426)		(403)		(837)		(778)
Interest expense | $	684,000		676,000		1,369,000		1,351,000
Other (income) expense | $	(22,000)		(47,000)		100,000		59,000
Loss before income tax provision | €		(1,088)		(1,032)		(2,306)		(2,188)
Income tax provision | €		(14)		1		(42)		(7)
Net Loss		(1,002)	(1,031,000)	€ (1,031)	(2,348,000)	€ (2,348)	(2,195,000)	€ (2,195)
Other comprehensive income
Foreign currency translation adjustment		€ 1	0		(7,000)		7,000
Comprehensive loss | $	$ (1,101,000)		$ (1,031,000)		$ (2,355,000)		$ (2,188,000)
Basic and dilutive earnings per share | $ / shares	$ (0.00)		$ (0.00)		$ (0.01)		$ (0.01)
Weighted-average shares outstanding, basic and diluted | shares	303,757,622	303,757,622	303,757,622	303,757,622	303,757,622	303,757,622	303,757,622	303,757,622